Verastem (FRA:2VSA) Short Interest

View and export this data going back to 2012. Start your Free Trial

What is Verastem Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.

Competitive Comparison of Verastem's Short Interest

For the Biotechnology subindustry, Verastem's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Verastem's Short Interest Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Verastem's Short Interest distribution charts can be found below:

* The bar in red indicates where Verastem's Short Interest falls into.

Verastem (FRA:2VSA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Verastem Inc (FRA:2VSA) » Definitions » Short Interest

Comparable Companies

Traded in Other Exchanges

VSTM:USA 0LOV:UK

Address

117 Kendrick Street, Suite 500, Needham, MA, USA, 02494

Website

https://www.verastem.com

Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.

Verastem (FRA:2VSA) Headlines

No Headlines